Patient selection for revascularization procedures in adult Moyamoya disease based on dynamic perfusion computerized tomography with acetazolamide challenge (PCTA)

Neurosurgical Review

Volumn 33, Issue 2, 2010, Pages 225-233

  Andaluz, Norberto ^a   Choutka, Ondrej ^b   Vagal, Achala ^b   Strunk, Rhonda ^b   Zuccarello, Mario ^b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c MAYFIELD CLINIC   (United States)

Author keywords

Acetazolamide; Cerebrovascular reserve; CT perfusion; Moyamoya disease

Indexed keywords

ACETAZOLAMIDE;

ADULT; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; FEMALE; GRAFT PATENCY; HUMAN; MALE; MOYAMOYA DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; REVASCULARIZATION; STROKE;

EID: 77949656030     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10143-010-0237-x     Document Type: Article

References (37)

1. L Axel 1983 Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique Invest Radiol 8 94 99 10.1097/00004424- 198301000-00018
2. JC Baron 2001 Perfusion thresholds in human ischemia: historical perspective and therapeutic applications Cerebrovasc Dis 11 Suppl 1 2 8 10.1159/000049119 11244194
3. S Bisdas O Nemitz G Berding K Weissenborn B Ahl H Becker F Donnerstag 2006 Correlative assessment of cerebral blood flow obtained with perfusion CT and positron emission tomography in symptomatic stenotic carotid disease Eur Radiol 16 2220 2228 10.1007/s00330-006-0209-2 16583214 (Pubitemid 44349870)
4. F Calamante V Ganesan FJ Kirkham 2001 MR perfusion imaging in Moyamoya syndrome:potential implications for clinical evaluation of occlusive cerebrovascular disease Stroke 32 2810 2816 10.1161/hs1201.099893 1:STN:280:DC%2BD3Mnptlyguw%3D%3D 11739978
5. A Chen MH Shyr TY Chen HY Lai CC Lin PS Yen 2006 Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease AJNR 27 1876 1881 1:STN:280: DC%2BD28ngtVCjug%3D%3D 17032859
6. CP Derdeyn TO Videen KD Yundt SM Fritsch DA Carpenter RL Grubb WJ Powers 2002 Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited Brain 125 595 607 10.1093/brain/awf047 11872616
7. JD Eastwood MJ Alexander JR Petrella JM Provenzale 2002 Dynamic CT perfusion imaging with acetazolamide challenge for the preprocedural evaluation of a patient with symptomatic middle cerebral artery occlusive disease AJNR 23 285 287 11847056
8. CJ Eskey PC Sanelli 2005 Perfusion Imaging of Cerebrovascular Reserve Neuroimag Clin N Am 15 367 381 10.1016/j.nic.2005.05.002 (Pubitemid 41405770)
9. EG Hoeffner I Case R Jain SK Gujar GV Shah JP Deveikis RC Carlos BG Thompson MR Harrigan SK Mukherji 2004 Cerebral perfusion CT: technique and clinical applications Radiology 231 632 644 10.1148/radiol.2313021488 15118110 (Pubitemid 38668077)
10. M Honda Y Ezaki N Kitagawa K Tsutsumi Y Ogawa I Nagata 2006 Quantification of the regional cerebral blood flow and vascular reserve in Moyamoya disease using split-dose iodoamphetamine I 123 single-photon emission computed tomography Surg Neurol 66 155 159 10.1016/j.surneu.2005.08.022 16876609 (Pubitemid 44107428)
11. H Hoshi T Ohnishi S Jinnouchi S Futami S Nagamachi T Kodama K Watanabe T Ueda S Wakisaka 1994 Cerebral blood flow study in patients with Moyamoya disease evaluated by IMP-SPECT J Nucl Med 35 44 50 1:STN:280:DyaK2c%2Fps1Wmug%3D%3D 8271059
12. K Kaneko Y Kuwabara F Mihara T Yoshiura M Nakagawa A Tanaka M Sasaki H Koga K Hayashi H Honda 2004 Validation of the CBF, CBV, and MTT values by perfusion MRI in chronic occlusive cerebrovascular disease: a comparison with 15O-PET Acad Radiol 11 489 497 10.1016/S1076-6332(03)00722-0 15147613 (Pubitemid 38533852)
13. KH Kang HS Kim SY Kim 2008 Quantitative cerebrovascular reserve measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease: initial experience with angiographic correlation AJNR 29 1487 93 1:STN:280:DC%2BD1crpt1WlsQ%3D%3D 18499785
14. K Kikuchi K Murase H Miki Y Yasuhara Y Sugawara T Mochizuki J Ikezoe S Ohue 2002 Quantitative evaluation of mean transit times obtained with dynamic susceptibility contrast-enhanced MR imaging and with 133 Xe SPECT in occlusive cerebrovascular disease AJR 179 229 235 12076942
15. T Kudo S Fukuda 1976 Spontaneous occlusion of the circle of Willis: a disease entity, its pathology and clinical features Adv Neurol Sci 20 750 757
16. S Kuroda K Houkin H Kamiyama K Mitsumori Y Iwasaki H Abe 2001 Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolmide test predict it? Stroke 32 2110 2116 10.1161/hs0901.095692 1:STN:280:DC%2BD3MvpvVGktQ%3D%3D 11546904
17. Y Kuwabara Y Ichiya M Otsuka T Tahara R Gunasekera K Hasuo K Masuda T Matsushima M Fukui 1990 Cerebral hemodynamic change in the child and the adult with Moyamoya disease Stroke 21 272 277 1:STN:280:DyaK3c7mt1Oluw%3D%3D 2305403
18. Y Kuwabara Y Ichiya M Sasaki T Yoshida K Masuda K Ikezaki T Matsushima M Fukui 1997 Cerebral hemodynamics and metabolism in Moyamoya disease: a positon emission tomography study Clin Neurol Neurosurg 99 Suppl 2 S74 S78 10.1016/S0303-8467(97)00061-9 9409411
19. HY Lee JC Paeng DS Lee JS Lee CW Oh MJ Cho JK Chung MC Lee 2004 Efficacy assessment of cerebral arterial bypass surgery using statistical parametric mapping and probabilistic brain atlas on basal/acetazolamide brain perfusion SPECT J of Nucl Med 45 202 206
20. SK Lee DI Kim EK Jeong SY Kim SH Kim YK In DS Kim JU Choi 2003 Postoperative evaluation of Moyamoya disease with perfusion-weighted MR imaging: initial experience AJNR 24 741 747 12695215
21. DJ Lythgoe L Ostergaard SC William A Cluckie M Buxton-Thomas A Simmons HS Markus 2008 Quantitative perfusion imaging in carotid artery stenosis using dynamic susceptibility contrast-enhanced magnetic resonance imaging Magn Reson Imaging 18 1 11 10.1016/S0730-725X(99)00112-5
22. K Ogasawara A Ogawa T Yoshimoto 2002 Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study Stroke 33 1857 1862 10.1161/01.STR.0000019511.81583.A8 12105366 (Pubitemid 34761076)
23. A Ogawa T Yoshimoto J Suzuki Y Sakurai 1990 Cerebral blood flow in moyamoya disease, part1: correlation with age and regional distribution Acta Neurochir (Wien) 105 30 34 10.1007/BF01664854 1:STN:280:DyaK3M%2FltVOnsg%3D%3D
24. Y Okada T Shima M Nishida K Yamane T Yamada C Yamanaka 1998 Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult Moyamoya disease Stroke 29 625 630 1:STN:280:DyaK1c7msFCntQ%3D%3D 9506603
25. WJ Powers 1991 Cerebral hemodynamics in ischemic cerebrovascular disease Ann Neurol 29 231 240 10.1002/ana.410290302 1:STN:280:DyaK3M3lsVSjsQ%3D%3D 2042939
26. N-J Rim HS Kim YS Shin SI Kim 2008 Which CT perfusion parameter best reflects cerebrovascular reserve?: Correlation of acetazolamide-challenged CT perfusion with single-photon emission CT in moyamoya patients Am J Neuroradiol 29 1658 63 10.3174/ajnr.A1229 18617583
27. J Rogg M Rutigliano H Yonas DW Johnson S Pentheny RE Latchaw 1989 The acetazolamide challenge: imaging techniques designed to evaluate cerebral blood flow reserve AJR 153 605 612 1:STN:280:DyaL1MzkvFWisQ%3D%3D 2763961
28. T Schroeder 1986 Cerebrovascular reactivity to acetazolamide in carotid artery disease: enhancement of side-to-side CBF asymmetry indicates critically reduced perfusion pressure Neurol Res 8 231 236 1:STN:280:DyaL2s7hs1ajtA%3D%3D 2880314
29. HG Sullivan TB Kingsbury 4th ME Morgan RD Jeffcoat JD Allison JJ Goode DE McDonnell 1987 The rCBF response to Diamox in normal subjects and cerebrovascular disease patients J Neurosurg 67 525 534 10.3171/jns.1987.67.4. 0525 1:STN:280:DyaL1c%2FhtVWltA%3D%3D 3655890
30. J Suzuki N Kodama 1983 Moyamoya disease: a review Stroke 14 104 10 1:STN:280:DyaL3s7itFajtg%3D%3D 6823678
31. J Suzuki A Takaku 1969 Cerebral vascular 'Moyamoya disease': a disease showing abnormal net like vessels in base of brain Arch Neurol 20 288 299 1:STN:280:DyaF1M7jvFWqsA%3D%3D 5775283
32. H Touho J Karasawa H Ohnishi 1996 Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease Stroke 27 282 289 1:CAS:528:DyaK28XhsV2lurg%3D 8571424
33. A Waaijer IC van der Schaaf BK Velthuis M Quist MJ van Osch EP Vonken MS van Leeuwen M Prokop 2007 Reproducibility of quantitative CT brain perfusion measurements in patients with symptomatic unilateral carotid artery stenosis AJNR 28 927 932 1:STN:280:DC%2BD2s3os1SksQ%3D%3D 17494672
34. JE Wanebo S Amin-Hanjani C Boyd T Peery 2005 Assessing success after cerebral revascularization Skull Base 15 215 227 10.1055/s-2005-872597 16175231 (Pubitemid 41245763)
35. M Wintermark P Maeder JP Thiran P Schnyder R Meuli, et al. 2001 Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models Eur Radiol 11 1220 1230 10.1007/s003300000707 1:STN:280:DC%2BD38%2FitlCrtQ%3D%3D 11471616 (Pubitemid 32755601)
36. S Yamamoto M Watanabe T Uematsu K Takasawa M Nukata N Kinoshita 2004 Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT AJNR 25 242 247 14970024
37. H Yonas RR Pindzola 1994 Physiological determination of cerebrovascular reserves and its use in clinical management Cerebrovasc Brain Metab Rev 6 325 40 1:STN:280:DyaK2M7os1emtA%3D%3D 7880717